Statistics
Publications
123
Citations
15.5K
H-Index
57
Active since
1913
Martin H. Cohen is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and pharmacology.
Publications per year
1913–2013
123
123
Prognostic effect of weight loss prior tochemotherapy in cancer patients
William D. DeWys, Colin B. Begg, Philip T. Lavin et al. · The American Journal of Medicine · 1980 · 2.4K citations
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Martin H. Cohen, Yuan Li Shen, Patricia Keegan et al. · The Oncologist · 2009 · 648 citations · Full text
Medicine, Oncology, Pharmacology +12
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 577 citations · Full text
United States Food and Drug Administration Drug Approval Summary
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2004 · 500 citations
Medicine, Oncology, Pharmacology +15
1–5 of 123